Introduction
Fetal cystic hygroma (CH) is a congenital malformation of the lymphatic system characterized by the formation of large, fluid-filled cysts, typically in the neck region. While often associated with chromosomal abnormalities like Turner syndrome, the underlying cellular and molecular drivers of CH have remained poorly understood. Previous studies using bulk tissue analysis were unable to distinguish the specific contributions of individual cell types within the complex lesion environment. This study utilizes single-cell RNA sequencing (scRNA-seq) to provide the first high-resolution transcriptomic map of CH, identifying the specific cell populations and signaling pathways responsible for its progression.
Methods
Researchers analyzed lymphoid tissue samples from 10 fetuses (4 with CH and 6 normal controls) at 11–13 weeks of gestation. Using the 10x Genomics platform, they sequenced 81,849 individual cells. The bioinformatics pipeline involved unsupervised clustering and UMAP visualization via the Seurat package to identify 15 distinct cell types. To understand the functional landscape, the team performed KEGG pathway enrichment and used CellChat to map intercellular communication. Finally, regulatory networks were explored using the STRING database and KnockTF software to predict transcription factors governing key genes.
The Cellular Landscape of Cystic Hygroma
The scRNA-seq analysis identified 15 distinct cell clusters, including fibroblasts, macrophages, astrocytes, and various progenitor cells. While fibroblasts were the most abundant cell type—consistent with the fibrous nature of CH lesions—the most significant finding was a dramatic expansion of lymphatic endothelial cells (LECs) in CH patients compared to controls. Furthermore, the data suggests an abnormal differentiation process where hematopoietic stem cells and vascular progenitors may be misdirected toward an LEC fate, contributing to the overgrowth of lymphatic vessels.
Molecular Drivers: The VEGF Signaling Hub
Pathway analysis revealed that the Vascular Endothelial Growth Factor (VEGF) signaling pathway is the central driver of abnormality in CH. Specifically, the interaction between the ligand VEGFA and its receptor VEGFR2 (encoded by the KDR gene) was significantly heightened. In LECs, genes such as CLDN5, KDR, and CCL21 were significantly upregulated. Cell-cell communication mapping identified keratinocyte progenitor cells as major signal "senders," while LECs acted as primary "mediators" within this pathological VEGF network.
Regulatory Mechanisms: The STAT1-KDR Axis
A key discovery of this study is the identification of the transcription factor STAT1 as a potential master regulator of the disease. Regulatory modeling found that STAT1 has five potential binding sites within the promoter region of the KDR gene. This suggests that STAT1 drives the overexpression of VEGFR2, fueling a cycle of abnormal lymphatic proliferation. This STAT1-KDR axis represents a novel therapeutic target for managing severe cases of CH.
Conclusion and Future Directions
This study provides a comprehensive single-cell atlas of fetal cystic hygroma, highlighting the expansion of LECs and the activation of the VEGF signaling pathway as critical pathological features. While these bioinformatics findings are robust, the authors note that the STAT1-KDR axis requires experimental validation through functional assays like CRISPR knockouts. Future research with larger cohorts will be essential to generalize these findings across different clinical subtypes of CH and to explore the potential of VEGF or STAT1 inhibitors as therapeutic interventions.
Summary updated